Cost‐benefit analysis of clinical pharmacist intervention in preventing adverse drug events in the general chronic diseases outpatients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cost‐benefit analysis of clinical pharmacist intervention in preventing adverse drug events in the general chronic diseases outpatients

Published:2019-06-24 Issue:1 Volume:26 Page:115-124
ISSN:1356-1294
Container-title:Journal of Evaluation in Clinical Practice
language:en
Short-container-title:J Eval Clin Pract

Author:

Al‐Qudah Rajaa A.¹,Al‐Badriyeh Daoud²,Al‐Ali Farah M.¹,Altawalbeh Shoroq M.³,Basheti Iman A.¹^ORCID

Affiliation:

1. Department of Clinical Pharmacy and Therapeutics, Faculty of PharmacyApplied Science Private University Amman Jordan

2. College of Pharmacy, QU Health ClusterQatar University Doha Qatar

3. Department of Clinical Pharmacy, Faculty of PharmacyJordan University of Science and Technology Irbid Jordan

Publisher

Wiley

Subject

Public Health, Environmental and Occupational Health,Health Policy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jep.13209

Reference35 articles.

1. Comprehensive assessment of treatment related problems in hospitalized medicine patients in Jordan

2. Treatment related problems for outpatients with chronic diseases in Jordan: the value of home medication reviews

3. Drug-Related Morbidity and Mortality

4. Drug-Related Morbidity and Mortality: Updating the Cost-of-Illness Model

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost avoidance of pharmacist-led deprescribing using STOPPFrail for older adults in nursing homes;International Journal of Clinical Pharmacy;2024-07-05

2. Costs saved and avoided from pharmacist interventions to address drug-related problems identified from outpatient clinics in Jordan;PLOS ONE;2024-06-06

3. Acute COPD exacerbations and in-hospital treatment-related problems: An observational study;PLOS ONE;2024-06-06

4. Financial impact of medication reviews by clinical pharmacists to reduce in-hospital adverse drug events: a return-on-investment analysis;International Journal of Clinical Pharmacy;2024-02-05

5. Cost avoidance of pharmacist-led deprescribing using STOPPFrail for older adults in nursing homes;2023-12-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3